Skip to main content
. 2023 Jul 27;11:1153638. doi: 10.3389/fpubh.2023.1153638

Table 1.

Data collection on key populations and HIV-1 subtypes and recombinants, 1990–2015.

HET MSM PWID VERT CSW BLOOD Total
Number of datasets
GLOBAL (1990–2015) 538 (60.8%) 110 (12.4%) 98 (11.1%) 86 (9.7%) 20 (2.3%) 33 (3.7%) 885 (100%)
1990–1999 109 (56.5%) 18 (9.3%) 36 (18.7%) 18 (9.3%) 4 (2.1%) 8 (4.1%) 193 (100%)
2000–2004 106 (55.5%) 22 (11.5%) 28 (14.7%) 16 (8.4%) 10 (5.2%) 9 (4.7%) 191 (100%)
2005–2009 230 (73.0%) 35 (11.1%) 17 (5.4%) 19 (6.0%) 6 (1.9%) 8 (2.5%) 315 (100%)
2010–2015 86 (49.1%) 32 (18.3%) 17 (9.7%) 32 (18.3%) 0 (0.0%) 8 (4.6%) 175 (100%)
Caribbean 10 (76.9%) 3 (23.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 13 (100%)
Latin America 18 (40.0%) 8 (17.8%) 4 (8.9%) 12 (26.7%) 3 (6.7%) 0 (0.0%) 45 (100%)
Western and central Europe, and North America (WCENA) 56 (23.5%) 66 (27.7%) 44 (18.5%) 40 (16.8%) 0 (0.0%) 32 (13.4%) 238 (100%)
Eastern Europe and central Asia (EECA) 6 (27.3%) 2 (9.1%) 13 (59.1%) 1 (4.5%) 0 (0.0%) 0 (0.0%) 22 (100%)
South Asia 8 (61.5%) 0 (0.0%) 2 (15.4%) 0 (0.0%) 3 (23.1%) 0 (0.0%) 13 (100%)
Southeast Asia (SE Asia) 28 (50.0%) 1 (1.8%) 21 (37.5%) 5 (8.9%) 1 (1.8%) 0 (0.0%) 56 (100%)
East Asia 2 (6.2%) 16 (50.0%) 12 (37.5%) 1 (3.1%) 0 (0.0%) 1 (3.1%) 32 (100%)
Oceania 3 (30.0%) 7 (70.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 10 (100%)
Middle East and North Africa (MENA) 1 (50.0%) 0 (0.0%) 1 (50.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (100%)
West Africa 137 (90.1%) 4 (2.6%) 0 (0.0%) 6 (3.9%) 5 (3.3%) 0 (0.0%) 152 (100%)
East Africa 91 (83.5%) 0 (0.0%) 1 (0.9%) 9 (8.3%) 8 (7.3%) 0 (0.0%) 109 (100%)
Ethiopia 7 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 7 (100%)
Central Africa 39 (95.1%) 0 (0.0%) 0 (0.0%) 2 (4.9%) 0 (0.0%) 0 (0.0%) 41 (100%)
Southern Africa 132 (91.0%) 3 (2.1%) 0 (0.0%) 10 (6.9%) 0 (0.0%) 0 (0.0%) 145 (100%)
Number of participants
GLOBAL (1990–2015) 44,952 (58.2%) 19,835 (25.7%) 6,236 (8.1%) 4,128 (5.3%) 1,685 (2.2%) 448 (0.6%) 77,284 (100%)
1990–1999 10,021 (71.1%) 1,071 (7.6%) 2,333 (16.5%) 370 (2.6%) 277 (2.0%) 27 (0.2%) 14,099 (100%)
2000–2004 9,369 (57.5%) 3,602 (22.1%) 1,829 (11.2%) 406 (2.5%) 965 (5.9%) 131 (0.8%) 16,302 (100%)
2005–2009 13,845 (62.1%) 5,487 (24.6%) 1,510 (6.8%) 754 (3.4%) 443 (2.0%) 242 (1.1%) 22,281 (100%)
2010–2015 10,768 (46.4%) 9,293 (40.0%) 564 (2.4%) 2,539 (10.9%) 0 (0.0%) 48 (0.2%) 23,212 (100%)
Caribbean 662 (61.1%) 421 (38.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1,083 (100%)
Latin America 3,146 (60.3%) 883 (16.9%) 241 (4.6%) 828 (15.9%) 121 (2.3%) 0 (0.0%) 5,219 (100%)
Western and central Europe, and North America (WCENA) 6,485 (31.8%) 11,726 (57.5%) 1,390 (6.8%) 516 (2.5%) 0 (0.0%) 269 (1.3%) 20,386 (100%)
Eastern Europe and central Asia (EECA) 263 (25.3%) 75 (7.2%) 694 (66.7%) 8 (0.8%) 0 (0.0%) 0 (0.0%) 1,040 (100%)
South Asia 541 (73.6%) 0 (0.0%) 80 (10.9%) 0 (0.0%) 114 (15.5%) 0 (0.0%) 735 (100%)
Southeast Asia (SE Asia) 3,649 (54.1%) 425 (6.3%) 2,195 (32.5%) 319 (4.7%) 157 (2.3%) 0 (0.0%) 6,745 (100%)
East Asia 763 (10.3%) 4,885 (66.1%) 1,537 (20.8%) 22 (0.3%) 0 (0.0%) 179 (2.4%) 7,386 (100%)
Oceania 93 (10.1%) 826 (89.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 919 (100%)
Middle East and North Africa (MENA) 71 (64.0%) 0 (0.0%) 40 (36.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 111 (100%)
West Africa 9,286 (91.1%) 333 (3.3%) 0 (0.0%) 110 (1.1%) 465 (4.6%) 0 (0.0%) 10,194 (100%)
East Africa 9,347 (85.3%) 0 (0.0%) 59 (0.5%) 730 (6.7%) 828 (7.6%) 0 (0.0%) 10,964 (100%)
Ethiopia 230 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 230 (100%)
Central Africa 2,673 (93.5%) 0 (0.0%) 0 (0.0%) 186 (6.5%) 0 (0.0%) 0 (0.0%) 2,859 (100%)
Southern Africa 7,743 (82.3%) 261 (2.8%) 0 (0.0%) 1,409 (15.0%) 0 (0.0%) 0 (0.0%) 9,413 (100%)

BLOOD, blood/plasma transfusion associated infections; CSW, commercial sex workers; HET, heterosexual; MSM, men who have sex with men; PWID, people who inject drugs; VERT, vertical transmission (mother to child).